Literature DB >> 29914972

BCR-ABL+ acute myeloid leukemia: are we always dealing with a high-risk disease?

Nina Rosa Neuendorff1,2, Philipp Hemmati1, Renate Arnold1, Jana Ihlow1, Bernd Dörken1, Carsten Müller-Tidow2, Jörg Westermann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29914972      PMCID： PMC6020811          DOI： 10.1182/bloodadvances.2018015594

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  13 in total

1.  Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.

Authors:  S P Chantepie; M Michallet; D Blaise; S Maury; E Deconinck; R Tabrizi; N Contentin; M Mohty; S Nguyen; B Lioure; N Raus; R Peffault de Latour; I Yakoub-Agha; O Reman
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

2.  Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Authors:  Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; Simon M G Daenen; Marinus van Marwijk Kooy; Pierre Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

3.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

4.  Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.

Authors:  Philipp G Hemmati; Lam G Vuong; Theis H Terwey; Christian F Jehn; Philipp le Coutre; Olaf Penack; Il-Kang Na; Bernd Dörken; Renate Arnold
Journal:  Eur J Haematol       Date:  2016-10-22       Impact factor: 2.997

5.  Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.

Authors:  Alireza Salem; Sanam Loghavi; Guilin Tang; Yang O Huh; Elias J Jabbour; Hagop Kantarjian; Wei Wang; Shimin Hu; Rajyalakshmi Luthra; L Jeffrey Medeiros; Joseph D Khoury
Journal:  Am J Hematol       Date:  2017-04-06       Impact factor: 10.047

6.  Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.

Authors:  Richard F Schlenk; Konstanze Döhner; Silja Mack; Michael Stoppel; Franz Király; Katharina Götze; Frank Hartmann; Heinz A Horst; Elisabeth Koller; Andreas Petzer; Wolfgang Grimminger; Guido Kobbe; Axel Glasmacher; Hans Salwender; Heinz Kirchen; Detlef Haase; Stephan Kremers; Axel Matzdorff; Axel Benner; Hartmut Döhner
Journal:  J Clin Oncol       Date:  2010-08-30       Impact factor: 44.544

7.  Does BCR/ABL1 positive acute myeloid leukaemia exist?

Authors:  Ellie P Nacheva; Colin D Grace; Diana Brazma; Katya Gancheva; Julie Howard-Reeves; Lena Rai; Rosemary E Gale; David C Linch; Robert K Hills; Nigel Russell; Alan K Burnett; Panagiotis D Kottaridis
Journal:  Br J Haematol       Date:  2013-03-25       Impact factor: 6.998

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.

Authors:  Eunhee Han; Hyeyoung Lee; Myungshin Kim; Yonggoo Kim; Kyungja Han; Sung-Eun Lee; Hee-Je Kim; Dong-Wook Kim
Journal:  Blood Res       Date:  2014-03-24

10.  Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).

Authors:  Vladimir Lj Lazarevic; Myriam Labopin; Wu Depei; Ibrahim Yakoub-Agha; Anne Huynh; Per Ljungman; Nicolaas Schaap; Jan J Cornelissen; Natacha Maillard; Pietro Pioltelli; Tobias Gedde-Dahl; Stig Lenhoff; Mohamed Houhou; Jordi Esteve; Mohamad Mohty; Arnon Nagler
Journal:  Am J Hematol       Date:  2017-10-31       Impact factor: 10.047
View more
  3 in total

Review 1.  Straight to the Point-The Novel Strategies to Cure Pediatric AML.

Authors:  Monika Lejman; Izabela Dziatkiewicz; Mateusz Jurek
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 2.  NF-κB: A Druggable Target in Acute Myeloid Leukemia.

Authors:  Barbara Di Francesco; Daniela Verzella; Daria Capece; Davide Vecchiotti; Mauro Di Vito Nolfi; Irene Flati; Jessica Cornice; Monica Di Padova; Adriano Angelucci; Edoardo Alesse; Francesca Zazzeroni
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

3.  Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product.

Authors:  Emiko Kashima; Eri Nakano; Yasuyuki Watanabe; Hiroshi Imai; Koji Oka; Shinichi Kageyama; Isao Tanaka
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.